+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site



Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site



Beijing Da Xue Xue Bao. Yi Xue Ban 35 Suppl: 62-65



SARS coronavirus 3CL proteinase is the key enzyme for virus replication which may serve as the target for drug discovery against SARS. A 3D structure model has been built for SARS coronavirus 3CL proteinase by comparative protein modeling. A homodimer model of the proteinase was also built. Analysis of the dimeric interface suggests the 3CL proteinase may have dimer form in solution. The conformational flexibility of the active site has been simulated by molecular dynamics combined with multi-canonical sampling. The active site loops have two typical conformations which may be related to the conformational movement associated with the enzymatic reaction.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049603970

Download citation: RISBibTeXText

PMID: 12914221


Related references

Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer. Acta Crystallographica. Section F Structural Biology and Crystallization Communications 61(Pt 11): 964-966, 2005

PH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses. Journal of Molecular Biology 354(1): 25-40, 2005

Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design. Bioorganic and Medicinal Chemistry 12(9): 2219-2223, 2004

Enzymatic activity of the SARS coronavirus main proteinase dimer. Febs Letters 580(11): 2577-2583, 2006

Structure and dynamics of SARS coronavirus main proteinase (Mpro). Advances in Experimental Medicine and Biology 581: 585-591, 2006

Generation of predictive pharmacophore model for SARS-coronavirus main proteinase. European Journal of Medicinal Chemistry 40(1): 57-62, 2005

Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase. Peptides 27(4): 622-625, 2006

Coronavirus main proteinase structure Basis for design of anti-SARS drugs. Science 300(5626): 1763-1767, 2003

A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters. Chemistry and Biology 15(6): 597-606, 2008

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chemistry & Biology 11(10): 1445-1453, 2004

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300(5626): 1763-1767, 2003

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochemical & Biophysical Research Communications 308(1): 148-151, 2003

Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs. Bioorganic and Medicinal Chemistry 12(10): 2517-2521, 2004

Structure and dynamics of SARS coronavirus proteinase: The primary key to the designing and screening for anti-SARS drugs. ScienceAsia 29(2): 181-188, 2003